About Axa Parenterals Limited
Data last updated:
Axa Parenterals Limited is a public limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 July 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2005PLC148247. Its GSTIN is 05AAFCA3600E1ZF (Uttarakhand). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹7.5 Cr and a paid-up capital of ₹7.38 Cr. It is led by directors including Yasha Agarwal (Whole-Time Director) and Ruchir Gupta (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 703 – 704 Pearls Best Height – 2 Netaji Subhash Place Pitampura, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹231.46 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹18.14 Cr (net margin 7.8%) and EBITDA of ₹42.52 Cr (EBITDA margin 18.4%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 12% over five years.
The company has about 295 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹212.35 Cr and satisfied charges of ₹459.83 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website axapar.com.
Company details
Contact details
Axa Parenterals Limited's registered office is in Delhi, Delhi. Its website is axapar.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address703 – 704 Pearls Best Height – 2 Netaji Subhash Place Pitampura, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Axa Parenterals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Axa Parenterals are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Axa Parenterals Limited, buy the company report.
Financials of Axa Parenterals Limited
FY 2024 filings availableAxa Parenterals Limited reported revenue of ₹231.46 Cr (up 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 12% over five years, including 6% growth in the latest year. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹42.52 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹18.14 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.4% | ||||
| Net Profit Margin | 7.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Axa Parenterals Limited, buy the company report.
Board of directors of Axa Parenterals Limited
Axa Parenterals has 7 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Kumar Agarwal | Director | 22 Feb 2019 | 7 Years 8 Months | Current |
| Vikas Khanna | Director | 16 Aug 2019 | 7 Years 2 Months | Current |
| Yasha Agarwal Also directs: Heilsa Life Sciences Private Limited | Whole-Time Director | 01 Jan 2023 | 3 Years 9 Months | Current |
| Ruchir Gupta | Whole-Time Director | 01 Oct 2010 | 16 Years 0 Months | Current |
| Sumit Kumar Agarwal Also directs: Heilsa Life Sciences Private Limited, Goldenyellow Paper LLP, Omanand Papers Private Limited and 1 more | Whole-Time Director | 01 Oct 2010 | 16 Years 0 Months | Current |
| Vijaysing Krupalsing Bhandari Also directs: Heilsa Life Sciences Private Limited | Director | 16 Mar 2022 | 4 Years 7 Months | Current |
Peer comparison
Axa Parenterals Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Stallion Laboratories Pvt Ltd | ₹234.32 Cr (FY 2024) | 25.0% | Ahmedabad, Gujarat, India | |||
| Emil Pharmaceutical Industries Private Limited | ₹232.55 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Axa Parenterals Limitedthis company | ₹231.46 Cr (FY 2025) | ₹18.14 Cr | 7.8% | 6.0% | 295 | Delhi, India |
| Dosch Pharmaceuticals Private Limited | ₹229.86 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Ahlcon Parenterals (India) Limited | ₹229.53 Cr (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| Medopharm Private Limited | ₹229.32 Cr (FY 2025) | -9.0% | Chennai, Tamil Nadu, India | |||
| Hindustan Laboratories Limited | ₹227.37 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Axa Parenterals Limited, buy the company report.
Auditor
Axa Parenterals Limited is audited by A JAIN AGARWAL & CO. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A JAIN AGARWAL & CO. | FY 2024 | 013330C |
Shareholding
The shareholding of Axa Parenterals Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Axa Parenterals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Jul 2025 | 101146882 | Others | ₹15 Lakh | Open | |
| 18 Oct 2024 | 100995657 | Hdfc Bank Limited | ₹30 Lakh | Open | |
| 13 Oct 2023 | 100810815 | Others | ₹147 Cr | Open | |
| 18 Aug 2023 | 100779080 | Hdfc Bank Limited | ₹20.1 Lakh | Open | |
| 01 Jan 2022 | 100539293 | Others | ₹64.25 Cr | Open |
To see the full charge records of Axa Parenterals Limited, buy the company report.
Total charge records: 35 View all charges
Legal cases
No court or tribunal cases involving Axa Parenterals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Axa Parenterals Limited was last rated by Brickwork on 31 Mar 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Brickwork | 31 Mar 2021 |
To see the full credit ratings and regulatory alerts of Axa Parenterals Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Axa Parenterals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Axa Parenterals has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Heilsa Life Sciences Private Limited | U24100DL2021PTC387167 |
To see the full group structure of Axa Parenterals Limited, buy the company report.
Employees & EPFO
Axa Parenterals Limited has a workforce of 295 employees on its EPFO records as of Dec 18, 2024, across 1 active EPFO establishment.
GST
Axa Parenterals has 5 GST registrations: 4 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAFCA3600E1ZF | Uttarakhand | Active | 01 Jul 2017 |
| 19AAFCA3600E1Z6 | West Bengal | Active | 29 Jun 2019 |
| 24AAFCA3600E1ZF | Gujarat | Active | 29 Jun 2019 |
| 36AAFCA3600E1ZA | Telangana | Active | 29 Jun 2019 |
To see the full GST registrations and return filing status of Axa Parenterals Limited, buy the company report.
Recent activity
Axa Parenterals Limited has 18 board changes on record since 2005: 7 appointments and 11 cessations. The latest: Yasha Agarwal ceased to be Additional Director on 24 Feb 2023.
82 earlier events are in the company report.
Frequently asked questions
Axa Parenterals is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 July 2005 (21+ years old) and is registered under CIN U24232DL2005PLC148247.
Axa Parenterals has 7 current directors:
- Yasha Agarwal - Whole-Time Director
- Ruchir Gupta - Whole-Time Director
- Sumit Kumar Agarwal - Whole-Time Director
- Sunil Kumar Agarwal - Director
- Vikas Khanna - Director
- Vijaysing Krupalsing Bhandari - Director
- Puneet Kansal - Director
The latest financial statements of Axa Parenterals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Axa Parenterals is 05AAFCA3600E1ZF, registered in Uttarakhand. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 19AAFCA3600E1Z6 (West Bengal), 24AAFCA3600E1ZF (Gujarat), 36AAFCA3600E1ZA (Telangana).
The CIN (Corporate Identification Number) of Axa Parenterals is U24232DL2005PLC148247. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Axa Parenterals was incorporated on 22 July 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Axa Parenterals by revenue are Stallion Laboratories Pvt Ltd, Emil Pharmaceutical Industries Private Limited, Dosch Pharmaceuticals Private Limited, Ahlcon Parenterals (India) Limited, Medopharm Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Yasha Agarwal ceased to be Additional Director on 24 Feb 2023. Yasha Agarwal was appointed as Whole-Time Director on 01 Jan 2023. Vijaysing Krupalsing Bhandari ceased to be Additional Director on 30 Sep 2022. Axa Parenterals has 18 board changes on record in total.
Axa Parenterals can be reached through the website axapar.com. Its registered office is in Delhi, India.
The registered office of Axa Parenterals is at 703 – 704 Pearls Best Height – 2 Netaji Subhash Place Pitampura, Delhi, India – 110034.
Axa Parenterals operates in the pharma industry, in the drug formulation and development segment.